The report provides a detailed analysis essential for establishing a Terbutaline production plant. It encompasses all critical aspects necessary for Terbutaline production, including the cost of Terbutaline production, Terbutaline plant cost, Terbutaline production costs, and the overall Terbutaline production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Terbutaline production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Terbutaline is a quick-relief medication that is classified as a short-acting beta-2 agonist. It works by targeting and relaxing the smooth muscles surrounding the airways in the lungs, which widens them to improve airflow and make breathing easier during sudden attacks. It is prescribed for patients aged 12 and older suffering from reversible bronchospasm linked to conditions like asthma, chronic bronchitis, and emphysema.
It is also utilised in other forms of chronic obstructive pulmonary disease (COPD), where it effectively reduces symptoms like wheezing, shortness of breath, coughing, and chest tightness. It is also used as a tocolytic to temporarily halt premature labour contractions by similarly relaxing uterine smooth muscle, allowing more time for foetal development before delivery.
The market for Terbutaline is fuelled by growing incidences of respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). The worsening air pollution, urbanisation trends, increasing ageing population and growth in global healthcare expenditures contribute to its market growth.
The public awareness initiatives, advancements in delivery formats, including nebulisation solutions and fast-dissolving tablets for superior patient adherence, expand its applications. The industrial Terbutaline procurement is influenced by the availability of abundant generics and the presence of cost-effective API supplies from China and India. The strict GMP compliance requirements, quality consistency risks, and instability in raw material prices because of supply chain interruptions from geopolitical tensions or logistics issues further impact its sourcing.
Raw Material for Terbutaline Production
According to the Terbutaline production plant project report, the key raw materials used in the production of Terbutaline include 3,5-Dibenzyloxyacetophenone, Bromine, and N-benzyl-N-tert-butylamine.
Production Process of Terbutaline
The extensive Terbutaline production cost report consists of the following major industrial production process:
- From 3,5-Dibenzyloxyacetophenone: The production process of Terbutaline involves several steps. It starts with the bromination of 3,5-dibenzyloxyacetophenone to form 3,5-dibenzyloxybromoacetophenone. This bromo compound then undergoes nucleophilic substitution with N-benzyl-N-tert-butylamine, yielding an α-(substituted amino)ketone intermediate. The final step involves the reduction of this ketone to the corresponding alcohol, producing terbutaline sulphate as the final product.
Terbutaline is a beta-2 adrenergic agonist that has the molecular formula of C12H19NO3 and a molecular weight of 225.29 g/mol. It appears as a solid white to off-white powder. It has a melting point of 247 degree Celsius and shows high solubility in water, methanol, and ethanol. It has a logP value of 0.90 and pKa values of 8.86 (acidic phenolic OH) and 9.76 (basic amine) with a polar surface area of 72.72 Ų. It sulfate salt with a molecular weight of 548.64 g/mol and is very soluble in ethanol, dioxane, and ether but practically insoluble in water with a melting point of 36 degree Celsius. It is hygroscopic and centrally distributed with oral bioavailability of 14–15%, protein binding <25%, and a half-life of 2.9–3.4 hours.